Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
2.45%
operating margin TTM
-0.57%
revenue TTM
167.59 Million
revenue per share TTM
1.22$
valuation ratios | |
|---|---|
| pe ratio | 192.93 |
| peg ratio | 1.54 |
| price to book ratio | 2.94 |
| price to sales ratio | 4.56 |
| enterprise value multiple | 37.61 |
| price fair value | 2.94 |
profitability ratios | |
|---|---|
| gross profit margin | 87.99% |
| operating profit margin | -0.57% |
| pretax profit margin | 3.17% |
| net profit margin | 2.45% |
| return on assets | 1.04% |
| return on equity | 1.54% |
| return on capital employed | -0.3% |
liquidity ratio | |
|---|---|
| current ratio | 4.57 |
| quick ratio | 4.17 |
| cash ratio | 0.85 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 506.88 |
| operating cycle | 563.60 |
| days of payables outstanding | 67.02 |
| cash conversion cycle | 496.58 |
| receivables turnover | 6.43 |
| payables turnover | 5.45 |
| inventory turnover | 0.72 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.14 |
| debt equity ratio | 0.21 |
| long term debt to capitalization | 0.15 |
| total debt to capitalization | 0.17 |
| interest coverage | -0.28 |
| cash flow to debt ratio | 0.56 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.31 |
| cash per share | 2.52 |
| operating cash flow per share | 0.31 |
| free cash flow operating cash flow ratio | 0.99 |
| cash flow coverage ratios | 0.56 |
| short term coverage ratios | 2.95 |
| capital expenditure coverage ratio | 158.42 |
Frequently Asked Questions
When was the last time Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) reported earnings?
Aurinia Pharmaceuticals Inc. (AUPH) published its most recent earnings results on 07-11-2024.
What is Aurinia Pharmaceuticals Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)'s trailing twelve months ROE is 1.54%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Aurinia Pharmaceuticals Inc. (AUPH) currently has a ROA of 1.04%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did AUPH's net profit margin stand at?
AUPH reported a profit margin of 2.45% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is AUPH's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.57 in the most recent quarter. The quick ratio stood at 4.17, with a Debt/Eq ratio of 0.21.